-+ 0.00%
-+ 0.00%
-+ 0.00%

Covestro (DB:1COV) Stock Can Revenue Hold Up As Losses Deepen?

Simply Wall St·08/02/2026 01:34:12
语音播报

The market has spent the past few months treating Covestro as a recovery story, with the stock edging higher into the latest numbers. The earnings release instead lays bare a company still wrestling with heavy losses. Full year 2025 brought a reported loss of €644m on a trailing basis and a deeply negative basic earnings per share line, even as revenue sat above €12b.

For a chemicals producer that lives and dies on throughput and margins, the headline is simple: sales are ticking along while profitability remains firmly in the red. That gap between price and profit is what investors now have to weigh.

Is Covestro at 1x P/S a misunderstood recovery play, or just an unprofitable stock that looks cheap on the surface? See how the current share price lines up against fundamentals in the valuation analysis for Covestro

FY 2025 Earnings Summary

  • Revenue (Q4 2025 vs Q4 2024): €2,915m vs €3,376m (revenue declined)
  • Net Income or Loss (Q4 2025 vs Q4 2024): loss of €378m vs loss of €192m (loss widened)
  • Basic EPS (Q4 2025 vs Q4 2024): loss of €1.96 per share vs loss of €1.02 per share (loss per share increased)
  • Trailing 12 Month Net Income or Loss (FY 2025 vs FY 2024, TTM): loss of €644m vs loss of €266m (loss over the trailing period increased)

Prefer clean charts over another dense block of earnings numbers? See Covestro's full financial picture, with a clear focus on profitability trends, in the visual company report for Covestro.

DB:1COV Trailing 12-Month Earnings & Revenue History as at Aug 2026
DB:1COV Trailing 12-Month Earnings & Revenue History as at Aug 2026

Covestro bull case runs into profit reality

Bulls argue Covestro is on a recovery track, with new aliphatics isocyanate capacity, Pontacol and HDI asset integrations, and EV exposure setting up a turn in earnings and cash flow. The latest numbers do not yet back that up. Q4 2025 revenue of €2,915m shows volumes and pricing are holding to a degree, yet the quarter still produced a loss of €378m and a basic loss per share of €1.96. On a trailing basis the company reported a loss of €644m. That is a larger earnings hole to climb out of while integration work and capex continue. Share price gains over the past 90 days suggest some confidence in a recovery path, but the hard financial milestone that matters, a clear move back into positive earnings, has not been hit.

Bearish Covestro thesis finds support in earnings

The bear case centers on persistent margin pressure, heavy capex needs, and the risk that integration and cost savings arrive too slowly to repair earnings. The latest Q4 loss of €378m, compared with a loss of €192m a year earlier, points to a profitability problem that is becoming more severe, not less. The trailing loss of €644m reinforces concerns about cash generation and balance sheet flexibility while Covestro invests in capacity and HDI assets. Analysts who worried that pricing pressure and end market softness could overwhelm cost actions see some of that caution reflected here. Revenue above €12b shows the industrial footprint is intact, yet losses remain deep. That combination supports the idea that structural issues in pricing, mix, or cost base are not yet resolved.

Access the multi year profit and revenue analyst estimates for Covestro to see where the consensus models suggest Covestro’s recovery path could quietly break from today’s seemingly settled share price.

Stay Ahead With Simply Wall St

If Covestro's widening losses and low P/S ratio have you watching for a clearer turn in the numbers, register for free with Simply Wall St and add it to a Watchlist to track share price moves against fair value and key earnings updates. Once you decide to take a position, keep your holdings organised and cut through market noise with the Portfolio Command Center that surfaces only the most important changes. For a longer term view, use the Community to gauge how other investors are interpreting new data points and potential turning points in Covestro's story. By spotting hidden catalysts and risks early, you give yourself a better chance to act before the wider market catches up.

Seeking Alternatives Beyond Covestro?

Fresh stock ideas can move from quiet potential to full breakout quickly. Before the best entry points are gone and early momentum is flying, scan these under the radar lists and act now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.